Healthcare and Life Sciences

Format: 2016-12-04
Format: 2016-12-04
December 02, 2016 | 94 Pages | SKU: IRTNTR10993

Overview of the global ambulatory surgical centers market

Market research analysts at Technavio predict that the global ambulatory surgical centers market will grow steadily during the next four years and post a CAGR of more than 4% by 2020. This market research analysis identifies the increasing incidence of chronic diseases as one of the primary growth factors for the ambulatory surgery centers market. The constantly changing eating habits of people across the globe and the sedentary lifestyle greatly impacts the homeostasis of the body. This will make people susceptible to cardiovascular diseases and chronic illnesses. As a result, the coming years will witness an increase in the adoption of minimally invasive techniques such as radiofrequency ablation devices to treat chest and joint pains, dermatological conditions, and liver and kidney problems. Since ambulatory surgical centers use endoscopic procedures and surgical robots to increase the precision and ability of surgeons who perform minimally invasive procedures, a rise in the number of chronic disorders will consequently boost the revenue of outpatient surgery centers.

This market study estimates that in terms of geographic regions, the Americas will be the major revenue contributor to the ambulatory center market throughout the forecast period. The US will be the major contributor in this region where the rise in the incidence of gastrointestinal disorders and chronic diseases such as colon and rectal cancer and severe


December 02, 2016 | 87 Pages | SKU: IRTNTR10994

Global outlook of the respiratory disposable devices market

Technavio’s market research analysts predict the global respiratory disposable devices market to grow steadily during the forecast period and post a CAGR of around 5% by 2020. This industry research report identifies the increasing number of surgical procedures to be one of the major factors that will have a positive impact on the growth of the disposable respiratory devices market in the coming years. In addition to specialty surgeries such as colectomies and appendectomies, hospitals also perform orthopedic, trauma, ophthalmic, endoscopic, laparoscopic, and cosmetic surgeries. Anesthesia is usually administered to keep the patient unconscious during the painful surgical procedures. The recent years have witnessed a constant increase in the number of surgical procedures around the globe, especially in the European countries. This will drive the demand for anesthesia, which will subsequently boost the growth of the disposable respiratory equipment market.

This market research and analysis estimates that in terms of geographical regions, the Americas will be the major revenue contributor to the market throughout the next four years. The constantly increasing number of surgical procedures and respiratory diseases in the countries in North America and the presence of a number of respiratory therapists in countries such as Canada will bolster the market’s growth prospects in this region. Furthermore, the increasing acquisition of smaller hospitals in the region, which will lead to a rise in the number of emergency and operating rooms and ICUs will also aid in the growth of the market in the Americas.


December 01, 2016 | 79 Pages | SKU: IRTNTR10992

Outlook of the global nucleic acid testing market

The global market for nucleic acid testing will grow at a CAGR of nearly 10% by 2020. According to the analysts, eminent factors like the higher adoption rate of molecular point-of-care (POC) testing will aid in the strong growth of this market during the forecast period. POC testing provides immediate results in non-laboratory settings to support more patient-centered approaches to healthcare delivery. The sensory technology enables the rapid analysis of blood samples. In the molecular diagnosis field, there is a higher adoption for POC testing systems as it helps in glucose self-testing. Also, due to the high cost of clinical diagnostic devices, the preference for molecular POC testing has increased.

In terms of geography, the nucleic acid testing market will witness rapid growth in the Americas. The market in this region is dynamic, with the presence of more than 20 established companies that compete for the sales of nucleic acid testing systems and reagents. The market in this region also provides significant opportunities for vendors, particularly in the US, as private and government research institutes and pharmaceutical companies are extensively adopting genome engineering, next-generation sequencing and gene editing technologies.

Competitive landscape and key vendors

The global nucleic acid market is in nascent stage and is characterized by the presence of large (tier 1), medium (tier 2) and small sized companies (tier 3) companies. Most of the top tier companies are present in the Americas and Western Europe. However, in APAC (such as China) there are many local vendors that account for a major share of the market in some areas. Factors such as advances in technology and new product launches also help in increasing the level of competition among vendors.

Top vendors in this market are -


December 01, 2016 | 115 Pages | SKU: IRTNTR10989

Global market overview for ultrasound equipment

The global market for ultrasound equipment is expected to witness moderate growth until 2020 and will be affected by factors like recent advancements in image quality, volumetric ultrasound, and new technologies. The availability of detailed visualization technologies due to advancements in computer technology with real-time processing, improved b-mode technology, and the final data display quality is envisaged to result in the high adoption of ultrasound equipment among end-users. For instance, Toshiba's Superb Micro-Vascular Imaging software, designed for 2D images of vessels and the 3D versions of Aplio 300 and 500 systems, can visualize even small vessel beds with the Doppler flow, in either grayscale or false color 3D reform. The increasing availability of such equipment with advanced technologies, especially in terms of image quality and volumetric ultrasound, will result in this market’s steady CAGR of nearly 6% by 2020.

According to Technavio’s market research analyst, the global market for ultrasound equipment will be dominated by the Americas due to the growing adoption of advanced technologies like Doppler, 3D, 4D, 5D by the healthcare professionals. It has also been noted that the researchers and scientists from leading universities like North Carolina State University, Icahn School of Medicine at Mount Sinai, Mayo Clinic, and Sidney Kimmel Comprehensive Cancer Center, are investing time and money in research. This recent increase in the R&D spend by researchers and scientists in ultrasound technology is anticipated to have a positive impact on the growth of this market until the end of 2020.

Competitive landscape and key vendors

Globally, this market is highly dynamic due to the


Overview of the global hospital-acquired urinary tract infection testing market

Technavio’s market research analyst predicts the global hospital-acquired urinary tract infection testing market to grow at a CAGR of around 19% between 2016 and 2020. Urinary tract infection occupies the largest share in the HAIs category, and the number is constantly growing. This has encouraged several vendors to develop innovative testing products that will subsequently augment the demand for hospital-acquired urinary tract infection testing products. Several technological advancements have enhanced the testing procedures for urinary tract infection, as they are more precise, sensitive, generate faster outcomes, and provide a broader range of pathogen detection as compared with the most traditional methods. Moreover, the innovative techniques in bioinformatics and software programs help manage a massive amount of data and offer better-quality results from tests such as molecular diagnostics. These methods provide initiation of infection control practices, optimization of treatment selection, reduced hospital stay, and improved surveillance of infectious diseases. Also, hospitals are setting up infection control committees that focus on only HAIs. Such infection control committee is responsible for the evaluation and planning of evidence-based practice, resource allocation, and prioritization of matters related to infection control.

Geographically, the Americas dominated the market and accounted for the largest market share in 2015. The high prevalence of infectious diseases, leading to the increased demand for diagnostic products and services and focus on disease management has propelled market growth in this region. The US is the largest revenue contributor for the hospital-acquired UTI testing market in the Americas owing to the massive sales of


November 29, 2016 | 91 Pages | SKU: IRTNTR10968

Global outlook of the prostate cancer drugs market

Technavio’s market research analysts predict the global prostate cancer drugs market to grow steadily during the predicted period and post an impressive revenue of more than USD 10 billion by 2020. This industry research report identifies the preference of physicians towards the adoption of hormonal therapies to be one of the major factors that will have a positive impact on the growth of the drugs market for the treatment of prostate cancer. Hormonal therapies stop the growth of cancer cells by reducing the amount of testosterone in the body. Due to their effectiveness, hormonal therapies have an increased adoption among physicians. This increased preference will improve the sales of hormonal therapies including luteinising hormone blockers, GnRH blockers, anti-androgens, and abiraterone and will, in turn, propel the market’s growth prospects.

One of the major trends that will gain traction in this market is the advances in early stage diagnosis through new diagnostic methods. The emergence of novel diagnostic tests that will be more accurate than the conventional prostate-specific antigen (PSA) test will help scientists diagnose prostate cancer much better. New tests such as phi test, 4Kscore test, Progensa, TMPRSS2: ERG and ConfirmMDX will be more accurate in early stage diagnosis. This in turn, will enhance the patient pool and consecutively aid in the growth of the market.

Competitive landscape and key vendors

The market is characterized by the presence


Pages